Ildong Holdings Co., Ltd. (KRX:000230)

Market Cap	135.73B +60.5%
Revenue (ttm)	620.44B -1.9%
Net Income	67.54B
EPS	5,328.78
Shares Out	11.29M
PE Ratio	2.34
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,647
Average Volume	100,255
Open	12,270
Previous Close	12,270
Day's Range	11,940 - 12,370
52-Week Range	5,750 - 17,170
Beta	0.40
RSI	39.89
Earnings Date	Feb 6, 2026

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 72
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000230